Clinical Trial Update: A Prospective Study to Evaluate Clinical Outcomes in Anti-LGI1 Encephalitis

View source ↗

Summary

A prospective clinical trial is evaluating clinical outcomes in anti-LGI1 autoimmune encephalitis and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Encephalitis
• Leucine-rich Glioma-inactivated Autoimmune Encephalitis

Snippet

Sponsor: Shen Chun-Hong | Conditions: Autoimmune Encephalitis, Leucine-Rich Glioma Inactivated 1 Autoimmune Encephalitis | Status: RECRUITING